DNA breaks caused by recombination-activating gene 1 (RAG1) and activation-induced cytidine deaminase (AID) induce c-myc/immunoglobulin (Ig) heavy chain chromosomal translocations and thereby stimulate lymphomagenesis. However, constitutive expression of c-myc alone is not sufficient to induce lymphomas. Because RAG1 and AID activity occurs outside of Ig genes, we assessed whether these enzymes provide the secondary genetic lesions in El c-myc transgenic mice to promote lymphoma development. We found that the tumor incidence and tumor phenotype in El c-myc transgenic mice is similar in AID
Lymphomas encompass a variety of cancers specific to the lymphatic system, most of which are of B-cell origin. The etiology of these cancers is not known, but they are probably driven by genomic instabilities in B cells that result in chromosomal translocations or other mutagenic DNA lesions involving proto-oncogenes and tumor suppressor genes. Indeed, many lymphomas harbor chromosomal translocations involving immunoglobulin (Ig) genes (Crews et al., 1982; Dalla-Favera et al., 1982) such as the c-myc/Ig heavy chain (IgH) translocation. To investigate the oncogenic role of c-myc, Em c-myc transgenic (Tg) mice were generated by coupling the c-myc gene with the Ig-m enhancer (Adams et al., 1985) . B-cell lymphomas arise in these mice in a stochastic manner between 6 and 83 weeks of age (Harris et al., 1988) , derive from different stages of B-cell development and are usually monoclonal in origin (Adams et al., 1985; Prasad et al., 1996; Egle et al., 2004) . These data indicate that constitutive expression of c-myc alone is not sufficient to induce tumors and that secondary genetic lesions are required. Although mutation in genes such as pim-1, bmi-1, bla-1 (van Lohuizen et al., 1991) and components of ARF-Mdm2-p53 pathway (Eischen et al., 1999) are found to be associated with c-myc-induced lymphomagenesis, it is not known what enzyme(s) or factor(s) is responsible for these secondary mutations.
Recombination-activating gene (RAG)1/2 proteins initiate V(D)J recombination by generating dsDNA breaks at conserved recombination signal sequences in Ig genes. AID is specifically expressed in germinal center B cells (Muramatsu et al., 2000) and initiates somatic hypermutation and class switch recombination in Ig genes by deaminating cytidines within Ig genes (reviewed in (Di Noia and Neuberger, 2007) ). Numerous reports show that c-myc/IgH or bcl-2/IgH translocations are mediated by the RAG proteins (Korsmeyer, 1992; Raghavan et al., 2004) and by the AID enzyme (Ramiro et al., 2004 (Ramiro et al., , 2006 Franco et al., 2006b; Dorsett et al., 2007) , and indeed, these enzymes have been found to mutate or cause DNA breaks outside of Ig genes (Korsmeyer, 1992; Shen et al., 1998; Muschen et al., 2000; Pasqualucci et al., 2001; Franco et al., 2006a) reinforcing the possibility that many other genes are susceptible to AID-and RAG-mediated mutations. Although RAG proteins and AID mediate chromosomal translocations, it has yet to be established whether these enzymes play additional roles in subsequent transformation events.
c-myc-induced tumor incidence is not affected by AID deficiency
Em c-myc Tg mice develop a high frequency of malignant tumors of a mature B-cell phenotype, (Harris et al., 1988; Egle et al., 2004) suggesting that an enzyme expressed in mature B cells produces secondary lesions necessary for lymphoma development. To investigate whether AID, which is expressed in mature B cells, promotes secondary genetic lesions, we bred AID þ / þ , AID þ /À and AID À/À Em c-myc Tg mice. These mice were housed and examined in a specific pathogenfree (SPF) environment and were monitored daily for signs of morbidity and lymphoma development. To determine the overall survival, the date that moribund mice were euthanized or, in some cases, the date that mice were found dead was used. Survival analysis using the logrank test showed no statistical difference in overall survival (P ¼ 0.5832) among the three genotypes ( Figure 1a , left panel). The median survival time was B100 days for all genotypes.
Because AID is expressed in germinal center B cells, and germinal center reactions are initiated by foreign antigens, we hypothesized that housing mice in a conventional environment would enhance germinal center formation and AID expression. Indeed, we observed an increase in Peyer's patches and germinal center size in our conventional facility compared to the SPF facility, suggesting a higher level of immune activation (Figure 1b) . However, there was no difference in overall survival between AID þ /À and AID À/À Em c-myc mice housed in a conventional facility (logrank test, P ¼ 0.4987; Figure 1a , right panel). The median survival time in the conventional facility was B130 days for the AID þ /À and AID À/À Em c-myc mice, which was significantly longer than those in the SPF facility (see below). Gross pathology of AID-sufficient and -deficient Em c-myc Tg mice was also similar in both facilities (Supplementary Table 1 ). Hence, lack of AID does not have any impact on the incidence and pathology of c-myc-induced lymphomagenesis in Em c-myc Tg mice.
AID deficiency has no significant effect on incidence of mature B-cell lymphomas
We postulated that if AID were to play a role in lymphomagenesis, the frequency of mature B-cell lymphomas in AID À/À Em c-myc Tg mice would be significantly reduced because AID is only expressed in mature activated B cells (Muramatsu et al., 1999; Crouch et al., 2007) . Therefore, we used flow cytometry to categorize the developmental status of lymphomas, as previously described (Egle et al., 2004) . We defined mature B-cell lymphomas as B220 Figure 1A , lower panel). As has been documented previously (Adams et al., 1985; Prasad et al., 1996) , our flow cytometry results show that the majority of lymphomas were homogenous, specifically either pre-B or mature B cells (Supplementary Figure 1B , left and middle panels). All of the surface light chain-positive mature B-cell lymphomas were also positive for surface þ / þ , AID þ /À and AID À/À Em c-myc Tg mice housed in a specific pathogen-free (SPF) and conventional facilities. The genotypes of the mice are indicated next to the survival curves and n denotes the number of mice in each group. There was no significant difference in overall survival among the three strains in the SPF facility (logrank test, P ¼ 0.5832) and of the AID þ /À and AID À/À strains in the conventional facility (logrank test, P ¼ 0.4987). C57BL/6 AID þ /À mice (kindly provided by T Honjo, Kyoto University, Japan) were bred to Em c-myc Tg mice. AID was detected using the primers AID5 0 -GTGCAGCTTTCCTTTACCCAAC; AID3 0 -CAACTCAGACCGCTCT-CTCC and NeoR5 0 -GCCAGCTCATTCCTCCACTC and the following conditions: 30 cycles of 95 1C for 30 s, 58 1C for 30 s, 72 1C for 30 s using Taq polymerase. Mice were monitored daily for signs of morbidity and lymphoma development. Data were analysed using GraphPad Prism version 5.0. (b) A comparison of germinal center size as a percent of total B cells and Peyer's patch numbers in wild type mice raised in the SPF (n ¼ 3) and conventional facilities (n ¼ 3). Germinal center cells were identified by flow cytometry as staining positive for GL-7 and Fas. A representative fluorescence-activated cell sorting plot and compiled data are shown. Germinal center populations in WT spleens were identified using fluorescein isothiocyanate-conjugated anti-mouse GL7 (BD Pharmingen, San Diego, CA, USA) and biotin-conjugated anti-mouse Fas (clone 15A7; eBioscience, San Diego, CA, USA).
IgM, and the majority of these lymphomas also stained positive for IgD, emphasizing the pre-germinal center characteristics of lymphomas in Em c-myc Tg mice. As depicted in Supplementary Table 2, the frequency of mature B-cell lymphomas in AID þ / þ Em c-myc Tg mice in the SPF facility was approximately 67%, similar to that reported earlier (Egle et al., 2004) . Furthermore, there was no significant difference in the incidence of mature B-cell lymphomas in AID þ / þ , AID þ /À and AID À/À Em c-myc Tg mice (one-way analysis of variance, P ¼ 0.5729). Analysis of the tumor phenotype in the conventional environment also gave a similar result (Mann-Whitney test, P ¼ 0.2418) (Supplementary Table  2 ). Collectively these data argue that AID does not contribute to lymphomagenesis in Em c-myc Tg mice.
c-myc-induced tumor incidence is accelerated by RAG1-deficiency Many secondary 'hits' occur during the early stages of B-cell development because a significant number of Em c-myc Tg mice develop pre-B-cell lymphomas (Supplementary Tables 1 and 2 , Harris et al., 1988; Egle et al., 2004) . If RAG proteins were involved in generating these lesions, RAG1
À/À Em -myc Tg mice would exhibit a delay in lymphoma onset compared to their RAG1-sufficient littermates. We found that gross pathology of moribund/ dead RAG-sufficient and -deficient Em c-myc Tg mice was similar (Supplementary Table 1 ). As shown in Figure 2a , RAG1 À/À Em c-myc Tg mice had accelerated lymphomagenesis compared to their RAG1-sufficient littermates (Mantel Cox test, P ¼ 0.0033). We examined 5 tumors from RAG1 À/À Em c-myc Tg mice, and as expected, all tumors were of a pre-B-cell phenotype (data not shown). Although these data suggest that RAG1 may instead play a role in suppressing tumor formation (see below), it nevertheless suggests that RAG1 is dispensable for lymphomagenesis in Em c-myc Tg mice.
Reduced RAG1 expression in B cells does not impact c-myc lymphomagenesis
The data described above indicate that RAG1 protects mice from c-myc-induced lymphomas. However, it is possible that this result is due to the absence of T cells rather than a B-cell intrinsic effect. To circumvent this problem, we bred Em c-myc Tg mice to Ig-HEL Tg mice. The B cells in these mice express rearranged IgH and Ig light-chain genes specific for the HEL antigen and have undetectable levels of RAG1/2 and considerably reduced rearrangement of endogenous Ig genes (Fang et al., 1998) . In this way, we can examine the effect of reduced RAG expression on lymphomagenesis in the B-cell lineage in mice that harbor a normal T-cell population. As shown in Figure 2b , survival analysis shows that the Ig-HEL transgene has no statistically significant effect on lymphomagenesis in Em c-myc Tg mice (logrank test, P ¼ 0.7113). We phenotyped eight tumors from Ig-HEL Em c-myc Tg mice, and as expected, all tumors were B220 þ and IgM þ . Collectively, these data indicate that RAG proteins do not contribute to lymphomagenesis in Em c-myc Tg mice but suggest that RAG expression is somehow protecting mice from lymphoma development.
Earlier studies examined the contribution of the V(D)J recombination process toward lymphomagenesis þ / þ , RAG1 þ /À and RAG1 À/À Em c-myc Tg mice showed a significant difference in overall survival (logrank test, P ¼ 0.0033). C57BL/6 RAG1 À/À mice (stock number: 002216; Jackson Laboratories, Bar Harbor, ME, USA) were interbred with Em c-myc Tg mice (Adams et al., 1985) in the C57BL/6 background (stock number: 002728; Jackson Laboratories). PCR assays of tail DNA were used to genotype for RAG1, Em c-myc and immunoglobulin(Ig)-hen egg lysozyme (HEL) transgene as suggested by the Jackson Laboratory. (b) Overall survival of Em c-myc Tg mice with or without the heavy and light-chain Ig-HEL transgenes. There was no significant difference in the overall survival between the two different strains (logrank test, P ¼ 0.7113). C57BL/6 Ig-HEL mice (Goodnow et al., 1988; Mason et al., 1992) were obtained from Dr J Wither (Toronto). These mice have a transgene integrated into chromosome 15, which consists of an Ig-k and Ig-m transgene specific for HEL (Mason et al., 1992) . in myc overexpressing mice. One study examined lymphoma incidence in Em c-myc Tg mice in the scid background and found that there was no difference in the lifespan of scid/scid Em c-myc Tg mice and controls (Prasad et al., 1996) . In contrast, RAG1-deficient vavP-MYC17 mice lived substantially longer than RAG1-sufficient vavP-MYC17 mice (Smith et al., 2005) . These discrepancies could be attributed to the intrinsic difference between Em c-myc Tg and vav-MYC17 mice; whereas c-myc expression is restricted to the B-cell lineage in Em c-myc Tg mice, c-myc is constitutively expressed in every nucleated hemopoietic cell in vavP-MYC17 mice and these mice usually die of thymomas (Smith et al., 2005) . In contrast to these studies, we found that RAG1-sufficient Em c-myc Tg mice survived significantly longer than the RAG1-deficient Em c-myc Tg mice. One possible explanation for the accelerated death of RAG1 À/À Em c-myc Tg mice is that in the absence of RAG1, B-cell development is arrested at a stage of development that is prone to transformation events. However, as RAG1
À/À Em c-myc Tg mice are devoid of mature lymphocytes, an alternate explanation is that mature T cells are involved in an immunemediated antitumor response. Nevertheless, as lymphomagenesis occurs at a higher frequency in RAG1 À/À Em c-myc Tg mice than in controls, it suggests that RAG proteins are not necessary for lymphoma development. Indeed, this notion was confirmed using Em c-myc Tg mice that harbor the Ig-HEL transgenes, which express undetectable levels of RAG1/2 (Fang et al., 1998) but had a similar incidence of lymphomas to wild type Em c-myc Tg mice.
AID is another potential candidate that could impact mature B cell. However, we found that the tumor incidence and tumor phenotype in Em c-myc Tg mice is similar in AID þ / þ , AID þ /À and AID À/À backgrounds in both specific pathogen-free and conventional animal facilities, indicating that AID does not contribute to lymphoma development in Em c-myc Tg mice. Findings that genetically deficient Em c-myc Tg mice have accelerated lymphomagenesis (Prasad et al., 1996; Eischen et al., 1999; Egle et al., 2004) argue that if AID were to have an effect on lymphomagenesis, AID deficiency should have had an impact on survival in Em c-myc Tg mice. While we were undertaking this study, Kotani et al. (2007) reported a similar analysis addressing the role of AID in lymphomagenesis in Em c-myc Tg mice. In this report, AID-sufficient C57BL/6 Em c-myc Tg mice developed mature B-cell lymphomas at a rate which was comparable to ours (Kotani et al., 2007) . However, unlike our analysis, Kotani et al. (2007) observed statistically significant survival differences in the AID þ /À and AID þ / þ genotypes. Moreover, almost all of their AID À/À Em c-myc Tg mice developed pre-B-cell lymphomas, whereas we found that mature B-cell lymphomas frequently arise in AID À/À Em c-myc Tg mice. Differences in the two animal facilities or animal colonies in these two reports might have contributed to these discrepancies.
Our results combined with previous results (Ramiro et al., 2004 (Ramiro et al., , 2006 Franco et al., 2006b; Dorsett et al., 2007) suggest that the primary oncogenic role of AID is to induce c-myc/IgH translocations. Another possibility is that AID does not have an impact on lymphoma development when c-myc/IgH translocation events precede AID expression. This is because secondary hits may be created prior to or after c-myc overexpression by other developmentally regulated factors that precede AID expression. However, as AID creates c-myc/IgH translocations (Ramiro et al., 2004) , it is reasonable to assume that AID might have subsequent oncogenic actions. To this end, it would be appropriate to analyse mice that developmentally overexpress c-myc in mature B cells to examine the impact of AID on lymphomagenesis.
In this study, we noticed that Em c-myc Tg mice lived longer in our conventional facility compared to our SPF facility. Although these differences were not statistically different using the logrank test, there was a statistically significant difference using the Gehan-Breslow-Wilcoxon test (P ¼ 0.0304 comparing AID þ /À in both facilities, and P ¼ 0.0245 comparing AID À/À in both facilities). The Gehan-Breslow-Wilcoxon test gives more weight to deaths at early time points compared to the logrank test that gives equal weight to all time points. We do not know the basis for this difference in tumor onset in our two facilities. The main difference between the two facilities is that the cages are assembled in a non-aseptic environment in the conventional facility. Thus, we believe that the differences in the survival curves stem from increased exposure to pathogenic/commensal microorganisms (Figure 1b) . This finding combined with the finding that RAG1-deficient Em c-myc Tg mice succumb to lymphomas more rapidly than their WT littermates suggest an immune-mediated activity that suppresses lymphoma development in Em c-myc Tg mice.
